Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Perimeter Medical Imaging AI's cash to debt ratio for the quarter that ended in Jun. 2026 was 1.60.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Perimeter Medical Imaging AIcould pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Perimeter Medical Imaging AI's Cash-to-Debt or its related term are showing as below:
FRA:4PC'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: 29.21 Max: 150.49
Current: 2.88
During the past 13 years, Perimeter Medical Imaging AI's highest Cash to Debt Ratio was 150.49. The lowest was 0.09. And the median was 29.21.
FRA:4PC's Cash-to-Debt is ranked better than 59.03% of 842
companies
in the Medical Devices & Instruments industry
Industry Median: 1.635
vs FRA:4PC: 2.88
Perimeter Medical Imaging AI (FRA:4PC) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Perimeter Medical Imaging AI Cash-to-Debt Related Terms
Perimeter Medical Imaging AI Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Devices subindustry, Perimeter Medical Imaging AI's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perimeter Medical Imaging AI Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perimeter Medical Imaging AI's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Perimeter Medical Imaging AI's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perimeter Medical Imaging AI (FRA:4PC) has a Cash-to-Debt of 1.60 as of Jun. 2026. This is 95% below median its historical median of 29.21. Over the past decade, Perimeter Medical Imaging AI's Cash-to-Debt has ranged from 0.09 to 150.49. According to the industry distribution chart, Perimeter Medical Imaging AI ranks #345 out of 842 companies in the Medical Devices & Instruments industry, placing it in the top 41%.
Is Perimeter Medical Imaging AI's Cash-to-Debt too high?
Perimeter Medical Imaging AI's current Cash-to-Debt of 1.60 is 95% below median its 10-year median of 29.21. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 150.49. The Medical Devices & Instruments industry median Cash-to-Debt is 1.64. Perimeter Medical Imaging AI's value of 1.60 is 2.1% below this industry median. Based on the distribution chart, Perimeter Medical Imaging AI ranks #345 out of 842 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Perimeter Medical Imaging AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Perimeter Medical Imaging AI's Cash-to-Debt compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perimeter Medical Imaging AI ranks #345 out of 842 companies for Cash-to-Debt. This puts Perimeter Medical Imaging AI in the upper half of its industry. The industry median Cash-to-Debt is 1.64. Perimeter Medical Imaging AI's value of 1.60 is 2.1% below this benchmark. Historically, Perimeter Medical Imaging AI's own Cash-to-Debt has ranged from 0.09 to 150.49 over the past decade. While the company's 10-year median is 29.21 vs. the industry median of 1.64, Perimeter Medical Imaging AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.64, based on 842 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perimeter Medical Imaging AI's current Cash-to-Debt of 1.60 is 2.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perimeter Medical Imaging AI's current Cash-to-Debt is 1.60, which is 95% below median its own 10-year median of 29.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perimeter Medical Imaging AI stock overvalued right now?
Perimeter Medical Imaging AI (FRA:4PC) has a current Cash-to-Debt of 1.60. The stock's GF Value™ is €0.44, compared to a current price of €0.16 — trading 64.3% below its estimated fair value. The current Cash-to-Debt is 1.60, which is 95% below median its 10-year median of 29.21 and 2.1% below the Medical Devices & Instruments industry median of 1.64. Perimeter Medical Imaging AI's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Perimeter Medical Imaging AI (FRA:4PC), the current Cash-to-Debt is 1.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perimeter Medical Imaging AI (FRA:4PC) Overvalued in 2026?
Based on GuruFocus' analysis, Perimeter Medical Imaging AI stock appears to be undervalued.
The current stock price of €0.16 is trading 64.3% below its estimated GF Value™ of €0.44.
Key valuation signals for FRA:4PC:
Cash-to-Debt: 1.60 (95% below median its 10-year median of 29.21)
GF Value™: €0.44 vs. price of €0.16 (64.3% below fair value)
Industry Position: 2.1% below the Medical Devices & Instruments median (#345 of 842)
No single metric tells the full story. See the FRA:4PC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perimeter Medical Imaging AI Inc is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, imaging tools to address high unmet medical needs. Its flagship product, Perimeter S-Series OCT (Optical Coherence Tomography) is a pioneering medical imaging system that delivers ultra-high-resolution margin visualization of excised tissue specimens in the operating room.
29GF Score
Get the complete analysis for FRA:4PC
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4PC has been successfully added to your 
